Literature DB >> 21334388

Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).

Rodrigo Jiménez-García1, Cristina Rodríguez-Rieiro, Valentín Hernández-Barrera, Ana Lopez de Andres, Agustin Rivero Cuadrado, Angel Rodriguez Laso, Pilar Carrasco-Garrido.   

Abstract

We aim to assess the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects. To do so, we describe and compare the influenza vaccination coverage in the 2006/2007 campaign between the Autonomous Community of Madrid (ACM), where in year 2005 the recommendation was extended by 5 years to cover all those aged 60 and over, and other regions of Spain where the universally recommended age was 65 years and above. We used individualized secondary data provided by two surveys carried out in 2007 in ACM and in the rest of Spain. The total number of subjects included in the study was 21,948. For the 60-64 years age group influenza vaccination coverage was significantly higher 40.1% (CI 95% 36.4-43.8) in ACM residents than among residents in the Rest of Spain 29.1% (CI 95% 24.5-33.7). The difference in vaccine uptake was even greater, 59% (CI 95% 51.8-66.2) vs. 43.5%(CI 95% 34.3-52.7), when we compared subjects who suffered a chronic condition, which represents an indication for the anti-influenza vaccination. The results of the multivariate analysis show that the probability of a subject aged 60-64 living in ACM of being vaccinated was almost two times higher (OR 1.95 CI 95% 1.46-2.61) than a person of the same age who lived in a region of Spain where the universal recommendation for influenza vaccine started at 65 years. In conclusion, the available evidence indicates the effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects aged 60-64 years in our population.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334388     DOI: 10.1016/j.vaccine.2011.02.004

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Pandemic and seasonal vaccine coverage and effectiveness during the 2009-2010 pandemic influenza in an Italian adult population.

Authors:  Simona Costanzo; Francesco Gianfagna; Mariarosaria Persichillo; Francesca De Lucia; Francesca D Lucia; Angelita Verna; Modjenar Djidingar; Sara Magnacca; Francesca Bracone; Marco Olivieri; Maria Benedetta Donati; Giovanni de Gaetano; Licia Iacoviello
Journal:  Int J Public Health       Date:  2012-02-28       Impact factor: 3.380

2.  Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil.

Authors:  Joao Tonolio Neto; Gabriela Tannus Branco de Araujo; Anna Gagliardi; Amanda Pinho; Laure Durand; Marcelo Fonseca
Journal:  Hum Vaccin       Date:  2011-10-01

3.  Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.

Authors:  Isabel Jimenez-Trujillo; Ana López-de Andrés; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Juana María Santos-Sancho; Rodrigo Jiménez-García
Journal:  Hum Vaccin Immunother       Date:  2013-02-12       Impact factor: 3.452

4.  Low Levels of Influenza Vaccine Uptake among the Diabetic Population in Spain: A Time Trend Study from 2011 to 2020.

Authors:  Jose J Zamorano-Leon; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Javier de-Miguel-Diez; David Carabantes-Alarcon; Romana Albaladejo-Vicente; Rosa Villanueva-Orbaiz; Khaoula Zekri-Nechar; Sara Sanz-Rojo
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

5.  Coverage and predictors of vaccination against 2012/13 seasonal influenza in Madrid, Spain: analysis of population-based computerized immunization registries and clinical records.

Authors:  Rodrigo Jiménez-García; María D Esteban-Vasallo; Cristina Rodríguez-Rieiro; Valentín Hernandez-Barrera; M A Felicitas Domínguez-Berjón; Pilar Carrasco Garrido; Ana Lopez de Andres; Moises Cameno Heras; Domingo Iniesta Fornies; Jenaro Astray-Mochales
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

6.  Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles.

Authors:  Edward Gibson; Najida Begum; Federico Martinón-Torres; Marco Aurélio Safadi; Alfred Sackeyfio; Judith Hackett; Sankarasubramanian Rajaram
Journal:  J Mark Access Health Policy       Date:  2016-06-28

7.  Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015.

Authors:  Jason LeBlanc; May ElSherif; Lingyun Ye; Donna MacKinnon-Cameron; Ardith Ambrose; Todd F Hatchette; Amanda Ls Lang; Hayley D Gillis; Irene Martin; Walter H Demczuk; Craig LaFerriere; Melissa K Andrew; Guy Boivin; William Bowie; Karen Green; Jennie Johnstone; Mark Loeb; Anne McCarthy; Allison McGeer; Makeda Semret; Sylvie Trottier; Louis Valiquette; Duncan Webster; Shelly A McNeil
Journal:  BMJ Open Respir Res       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.